JORDAN DAVIS: Open Payments
NPI 1780277608 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,048 in 44 payments from 13 companies in 2025. Trend: 2023 $287 · 2024 $495 · 2025 $3,048
Food & beverage: $1,718Travel & lodging: $1,330
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 25 | $2,345 |
| Axsome Therapeutics, Inc. | 3 | $190 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| Alkermes, Inc. | 1 | $87 |
| ABBVIE INC. | 1 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Globus Medical, Inc. | 2 | $35 |
| Medtronic, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: Evoke, Auvelity, COBENFY, LYBALVI, VRAYLAR, RELISTOR, Senza, INTELLIS ADAPTIVESTIM.
Industry payments across LA — which companies pay providers there.
